Clinical Trial Update: Safety and Efficacy Study of APD125 in Patient With Insomnia [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 safety and efficacy study of APD125 in patients with insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• APD125

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Insomnia | Phase 2 | Status: COMPLETED